Clarity Pharmaceuticals Ltd financials at a glance

+ Portfolio

The revenue of Clarity Pharmaceuticals Ltd is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -0.1 Dollars per share in 2023, which was 11.11 lower than 2022. And about -0.02755 billion Dollars are reported as free cash flow in the financials of Clarity Pharmaceuticals Ltd 2023. No dividends were paid to the shareholders of the Clarity Pharmaceuticals Ltd stock ASX:CU6 in the financial year 2023.

$0.00M

Revenue

$-0.10

Earnings Per Share

100.00%

Gross Margin %

$-27.55M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-0.10

Gross Margin %

100.00

Free Cash Flow

-27.55

Financials

Year	Year	TTM	2023	2022
Rev.	Revenue	N/A	$0.00M	$6.55M
GM %	Gross Margin %	100.00%	100.00%	100.00%
OM	Operating Margin	-,269.00%	-,269.00%	-,263.94%
EPS	Earnings Per Share	$-0.10	$-0.10	$-0.09
Div.	Dividends	N/A	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	0
Sha.	Shares	N/AM	260.66M	257.94M
OCF	Operating Cash Flow	N/A	$-27.50M	$-13.31M
FCF	Free Cash Flow	N/A	$-27.55M	$-13.53M
FCFS	Free Cash Flow Per Share	$-0.11	$-0.11	$-0.05

Clarity Pharmaceuticals Ltd financials at a glance

Financials

Discover